Your session is about to expire
← Back to Search
FAIR Program for Substance Use Disorders (PRE-FAIR Trial)
N/A
Waitlist Available
Led By Lisa Saldana, PhD
Research Sponsored by Chestnut Health Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 16 to 30 at date of intake assessment
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of study, up to 4 years
Awards & highlights
No Placebo-Only Group
Summary
This trial offers the potential to deliver a new outpatient prevention program to high-risk, young parents in order to help address the opioid and methamphetamine use disorders crisis in Oregon.
Who is the study for?
This trial is for young parents aged 16 to 30 in Oregon who are at risk for opioid or methamphetamine addiction and have a child or a plan to reunite with their child. They must not have misused opioids or used meth more than three times last year, be involved with DHS, and live in a participating county.
What is being tested?
The study compares the FAIR program—a community-based prevention service including mental health and parenting support—with standard case management for preventing substance misuse among high-risk parents. It will involve 240 participants randomized into two groups across two counties.
What are the potential side effects?
Since this trial involves social services rather than medical treatments, traditional side effects like those seen with medications are not applicable. However, there may be emotional or psychological impacts from participation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 16 and 30 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of study, up to 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of study, up to 4 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Completion of Key Intervention Implementation Activities Over the Course of the Study
Costs Associated with Key Intervention Implementation Activities Over the Course of the Study
Mean Changes From Baseline in Parenting Behaviors as Assessed by the BCAP at 24-months Post-Baseline
+10 moreSecondary study objectives
Descriptive Measures of FAIR Program Delivery
Mean Levels of Client Satisfaction with Services at the End of Treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pre-FAIRExperimental Treatment1 Intervention
Participants in this arm will receive the FAIR intervention.
Group II: ControlActive Control1 Intervention
Participants in this arm will receive services standard case management and services .
Find a Location
Who is running the clinical trial?
Chestnut Health SystemsLead Sponsor
23 Previous Clinical Trials
23,360 Total Patients Enrolled
Oregon Social Learning CenterLead Sponsor
35 Previous Clinical Trials
10,534 Total Patients Enrolled
Lisa Saldana, PhDPrincipal InvestigatorChestnut Health Systems
4 Previous Clinical Trials
1,216 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not used opioids improperly or used methamphetamine more than 3 times in the last year.I am between 16 and 30 years old.I am a parent of a child who is 18 years old or younger.I have a child at home or a plan to reunite with my child.
Research Study Groups:
This trial has the following groups:- Group 1: Pre-FAIR
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Child Neglect Patient Testimony for trial: Trial Name: NCT05380440 — N/A